This suggests that the GIP receptor could be a potential target for the prevention and treatment of osteoporosis [50], Fig
Prevalence, time trends and treatment practices of asthma in India: the global asthma network study
iTRAQ-based quantitative protein expression profiling and MRM verification of markers in type 2 diabetes
As a result of this, FOXO4-DRI peptide may be less susceptible to the normal clearance mechanism as compared to FOXO4
High dose oral cobalamin would be a reasonable alternative as maintenance in patients unable to tolerate intramuscular injections provided there is good compliance with treatment
and has received research support from Boehringer-Ingelheim, Eli Lilly &, Merck, Sharp & Dohme, Novo Nordisk, and Sanofi